In studies that have investigated the expression levels of RAGE in tissues [10,12], expression was found to decrease as lung cancer progressed or lymph node metastasis developed, but we found no significant difference in serum or bronchial sRAGE levels by lung cancer stage or type. Here, AGER is linked to lung carcinoma.